Research graph
References from From benchmarking to global leadership: Singapore’s health sciences authority’s journey to WHO maturity level 4 and WHO-Listed Authority status for medicines. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2014 · External reference
Unresolved reference
2021 · External reference
Unresolved reference
2018 · External reference
The WHO global benchmarking tool: a game changer for strengthening national regulatory capacity
10.1136/bmjgh-2020-0031 · 2020 · External reference
Unresolved reference
2019 · External reference
Unresolved reference
2023 · External reference
Unresolved reference
2021 · External reference
Unresolved reference
2022 · External reference
Unresolved reference
2022 · External reference
WHO-listed authorities (WLA) framework: transparent evidence-based approach for promoting regulatory reliance towards increased access to quality-assured medical products
10.3389/fmed.2024.1467229 · 2024 · External reference
Advancements in regulatory agility, regional collaboration, and digital transformation: insights from the Asia partnership conference of pharmaceutical associations (APAC)
10.1186/s41120-024-00102-2 · 2024 · External reference
Unresolved reference
2025 · External reference
Unresolved reference
2019 · External reference
Unresolved reference
2023 · External reference
Unresolved reference
2024 · External reference
Unresolved reference
2025 · External reference
Unresolved reference
2024 · External reference
Unresolved reference
2025 · External reference
Unresolved reference
2025 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
2026 · External reference
